OP 7.3 – 00139 Pre-treatment Interruption Plasma Metabolites and Glycans Correlate with Time to HIV Rebound and Reservoir Size in ACTG A5345

• L.B. Giron,
• X. Yin,
• S.G. Deeks,
• R.T. Gandhi,
• A. Landay,
• Q. Liu,
• B.J. Macatangay,
• D.M. Smith,
• J.Z. Li,
• M. Abdel-Mohsen

Affiliations

L.B. Giron

The Wistar Institute, Philadelphia, PA, USA

X. Yin

The Wistar Institute, Philadelphia, PA, USA

S.G. Deeks

University of California San Francisco, San Francisco, CA, USA

R.T. Gandhi

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

A. Landay

Rush University, Chicago, IL, USA

Q. Liu

The Wistar Institute, Philadelphia, PA, USA

B.J. Macatangay

University of Pittsburgh, Pittsburgh, PA, USA

D.M. Smith

University of California San Diego, San Diego, CA, USA

J.Z. Li

Brigham and Women's Hospital, Harvard Medical School, San Francisco, CA, USA

M. Abdel-Mohsen

The Wistar Institute, Philadelphia, PA, USA